155 related articles for article (PubMed ID: 1359908)
1. Synthesis and beta-adrenergic antagonist activity of novel (3-oxazolinyl-1,4-dihydropyridyl) propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1992 Jul; 8(4):265-72. PubMed ID: 1359908
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1991 Dec; 8(2):157-64. PubMed ID: 1686561
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cardioselective beta-adrenergic antagonist activity of quinolyloxypropanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1992; 9(1):69-78. PubMed ID: 1360842
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and adrenergic beta-blocking activity of ortho-, meta- and para-oxypropanolamino-substituted [(benzylideneamino)oxy]propanolamines.
Balsamo A; Lapucci A; Macchia B; Macchia M; Orlandini E; Rossello A; Ferni G; Pinza M
Farmaco; 1995 Apr; 50(4):239-43. PubMed ID: 7669168
[TBL] [Abstract][Full Text] [Related]
6. beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines.
Lemke TL; Cramer MB; Adamski SW; Pedone CA; Brooker G
J Med Chem; 1981 Oct; 24(10):1211-4. PubMed ID: 6120233
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and beta-adrenergic activity of new completely aliphatic 3-(methyleneaminoxy)propanolamine derivatives.
Balsamo A; Gentili D; Lapucci A; Macchia M; Martinelli A; Orlandini E; Ferni G; Pinza M
Farmaco; 1994 Dec; 49(12):759-66. PubMed ID: 7893332
[TBL] [Abstract][Full Text] [Related]
8. Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
Hoefle ML; Hastings SG; Meyer RF; Corey RM; Holmes A; Stratton CD
J Med Chem; 1975 Feb; 18(2):148-52. PubMed ID: 235644
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
[TBL] [Abstract][Full Text] [Related]
10. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
Leclerc G; Decker N; Schwartz J
Arzneimittelforschung; 1985; 35(9):1357-67. PubMed ID: 2867769
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols.
Gombar V
Arzneimittelforschung; 1986 Jul; 36(7):1014-8. PubMed ID: 2876713
[TBL] [Abstract][Full Text] [Related]
12. [On the synthesis of compounds with beta-adrenergic activity (author's transl)].
Lehmann D; Eckardt R; Faust G; Fiedler W
Pharmazie; 1980; 34(5-6):278-84. PubMed ID: 6106206
[TBL] [Abstract][Full Text] [Related]
13. Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols.
Condon ME; Cimarusti CM; Fox R; Narayanan VL; Reid J; Sundeen JE; Hauck FP
J Med Chem; 1978 Sep; 21(9):913-22. PubMed ID: 31485
[TBL] [Abstract][Full Text] [Related]
14. [Adrenergic beta receptor blockaders. IV. 1-(Hydroxy- or dihydroxyphenoxy)-3-isopropylamino-2-propanols].
Casagrande C; Ferrini R; Miragoli G; Ferrari G
Boll Chim Farm; 1973 Jul; 112(7):445-54. PubMed ID: 4148774
[No Abstract] [Full Text] [Related]
15. [Synthesis of 2-{3-[4-(4-fluorophenyl)-1-piperazinyl]-2-hydroxy-propoxy}-phenylcarbamic acid alkylesters and in vitro evaluation of their beta-antiadrenergic and vasodilatative activities].
Gonec T; Racanská E; Csöllei J
Ceska Slov Farm; 2008 Jun; 57(3):115-8. PubMed ID: 18683428
[TBL] [Abstract][Full Text] [Related]
16. Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function.
Erhardt PW; Woo CM; Anderson WG; Gorczynski RJ
J Med Chem; 1982 Dec; 25(12):1408-12. PubMed ID: 6130154
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic blocking agents: substituted phenylalkanolamines. Effect of side-chain length on beta-blocking potency in vitro.
Fuhrer W; Ostermayer F; Zimmermann M; Meier M; Müller H
J Med Chem; 1984 Jul; 27(7):831-6. PubMed ID: 6145802
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine.
Cecchetti V; Fravolini A; Fringuelli R; Schiaffella F; Mascellani G; Pagella PG; Rugarli PL
Farmaco Sci; 1987 Jan; 42(1):61-75. PubMed ID: 2898382
[TBL] [Abstract][Full Text] [Related]
19. [(Arylcarbonyl)oxy]propanolamines. 1. Novel beta-blockers with ultrashort duration of action.
Kam ST; Matier WL; Mai KX; Barcelon-Yang C; Borgman RJ; O'Donnell JP; Stampfli HF; Sum CY; Anderson WG; Gorczynski RJ
J Med Chem; 1984 Aug; 27(8):1007-16. PubMed ID: 6146718
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxic activity of (E)-1-(2-nitrovinyl) and 1-[N-(tert-butylformiminyl)]-substituted 1,4-dihydropyridines and 2-pyridones.
Im C; Knaus EE; Thuynsma RP; Allen TM
Drug Des Deliv; 1990 Mar; 5(3):239-48. PubMed ID: 1670504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
